APPLICATION OF METHYLTRANSFERASE HEN1 FOR ANALYSIS OF SMALL NON-CODING RIBONUCLEIC ACIDS

Aleksandr Osipenko1, Alexandra Plotnikova1, Viktoras Masevičius1, Giedrius Vilkaitis1, Saulius Klimašauskas1

1 Institute of Biotechnology, Vilnius University, Lithuania

Small non-coding ribonucleic acids (RNAs) such as microRNAs (miRNAs) and small-interfering RNAs (siRNAs) are among the most studied biological objects of the last decade. Present in the widest range of eukaryotes, including humans, these small molecules with its numerous functions have high importance in almost all main biological processes [1]. It is not surprising that differences in small RNA levels were determined as potential biomarkers in cancer, neurological and many other diseases [2, 3, 4]. However detection and extraction of these molecules are still challenging to scientists.

Here we present novel fast and easy one-step labeling of small RNAs (Fig. 1, A) that allows extraction of these molecules and more labile two-step labeling (Fig. 1, B) that provides wide selection of different reporter groups, such as biotin and fluorophores. Both methods use synthetic analogues of S-adenosyl-L-methionine (Fig. 1, 1 and 2) and exploit high specificity of methyltransferase HEN1 to double-stranded 21 to 24 nucleotides long RNA molecules, namely miRNA and siRNA duplexes, minimizing non-specific detection and/or extraction of deoxyribonucleic acids or irrelevant types of ribonucleic acids molecules, such as transfer RNAs or fragments of long RNAs.

Figure 1
Fig. 1. One-step (A) and two-step (B) labeling of small RNAs by HEN1 methyltransferase using synthetic analogues of S-adenosyl-L-methionine (1 and 2).

[1] D. P. Bartel, MicroRNA Target Recognition and Regulatory Functions, Cell 136, 215-233 (2009).

[2] G. Di Leva, M. Garofalo and C. M. Croce, MicroRNAs in Cancer, Annual Review of Pathology 9, 287-314 (2014).

[3] P. J. Mishra, MicroRNAs as promising biomarkers in cancer diagnostics, Biomarker Research 2, 19 (2014).

[4] P. Rao, E. Benito and A. Fischer, MicroRNAs as biomarkers for CNS disease, Frontiers in Molecular Neuroscience 6, 39 (2013).